Relay Therapeutics, Inc.
RLAY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$338 | -$342 | -$291 | -$364 |
| Dep. & Amort. | $5 | $5 | $4 | $4 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $94 | $86 | $56 | $48 |
| Change in WC | $15 | -$32 | $11 | $97 |
| Other Non-Cash | -$26 | -$17 | -$10 | $140 |
| Operating Cash Flow | -$249 | -$300 | -$229 | -$74 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$4 | -$9 | -$3 |
| Net Acquisitions | $0 | $0 | $180 | -$25 |
| Inv. Purchases | -$651 | -$386 | -$535 | -$981 |
| Inv. Sales/Matur. | $612 | $647 | $356 | $530 |
| Other Inv. Act. | $0 | $0 | -$180 | $0 |
| Investing Cash Flow | -$41 | $258 | -$189 | -$480 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $266 | $30 | $285 | $382 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $4 | $4 | $5 | $6 |
| Financing Cash Flow | $270 | $35 | $290 | $388 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$20 | -$8 | -$128 | -$166 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $146 | $154 | $283 | $449 |
| End Cash | $126 | $146 | $154 | $283 |
| Free Cash Flow | -$251 | -$304 | -$239 | -$78 |